{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:56:46Z","timestamp":1715579806776},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10528-023-10437-2","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T10:02:00Z","timestamp":1688205720000},"page":"530-546","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities"],"prefix":"10.1007","volume":"62","author":[{"given":"Shaun V.","family":"Charkowick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha I.","family":"Huda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruv N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Yeagley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F.","family":"Arturo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad J.","family":"Cios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne C.","family":"Gozlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Chobrutskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris I.","family":"Chobrutskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"key":"10437_CR1","doi-asserted-by":"publisher","first-page":"D816","DOI":"10.1093\/nar\/Gkn673","volume":"37","author":"LG Almeida","year":"2009","unstructured":"Almeida LG, Sakabe NJ, deOliveira AR, Silva MC, Mundstein AS, Cohen T et al (2009) Ctdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res 37:D816\u2013D819. https:\/\/doi.org\/10.1093\/nar\/Gkn673","journal-title":"Nucleic Acids Res"},{"key":"10437_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0328-8","author":"JF Arturo","year":"2019","unstructured":"Arturo JF, Chobrutskiy BI, Yeagley M, Patel DN, Falasiri S, Patel JS et al (2019) Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates. Cell Mol Immunol. https:\/\/doi.org\/10.1038\/s41423-019-0328-8","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"10437_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41423-019-0328-8","volume":"17","author":"JF Arturo","year":"2020","unstructured":"Arturo JF, Chobrutskiy BI, Yeagley M, Patel DN, Falasiri S, Patel JS et al (2020) Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates. Cell Mol Immunol 17(7):776\u2013778. https:\/\/doi.org\/10.1038\/s41423-019-0328-8","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10437_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/aje\/kwp332","volume":"171","author":"V Bagnardi","year":"2010","unstructured":"Bagnardi V, Randi G, Lubin J, Consonni D, Lam TK, Subar AF et al (2010) Alcohol consumption and lung cancer risk in the environment and genetics in lung cancer etiology (EAGLE) study. Am J Epidemiol 171(1):36\u201344. https:\/\/doi.org\/10.1093\/aje\/kwp332","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10437_CR5","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/j.cllc.2020.06.003","volume":"22","author":"C Behrens","year":"2021","unstructured":"Behrens C, Rocha P, Parra ER, Feng L, Rodriguez-Canales J, Solis LM et al (2021) Female gender predicts augmented immune infiltration in lung adenocarcinoma. Clin Lung Cancer 22(3):e415\u2013e424. https:\/\/doi.org\/10.1016\/j.cllc.2020.06.003","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10437_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13073-015-0248-x","volume":"7","author":"SD Brown","year":"2015","unstructured":"Brown SD, Raeburn LA, Holt RA (2015) Profiling tissue-resident T cell repertoires by RNA sequencing. Genome Med 7(1):125. https:\/\/doi.org\/10.1186\/s13073-015-0248-x","journal-title":"Genome Med"},{"issue":"2","key":"10437_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12026-018-8990-y","volume":"66","author":"BM Callahan","year":"2018","unstructured":"Callahan BM, Tong WL, Blanck G (2018a) T cell receptor-beta J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates. Immunol Res 66(2):219\u2013223. https:\/\/doi.org\/10.1007\/s12026-018-8990-y","journal-title":"Immunol Res"},{"issue":"6","key":"10437_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00262-018-2139-7","volume":"67","author":"BM Callahan","year":"2018","unstructured":"Callahan BM, Yavorski JM, Tu YN, Tong WL, Kinskey JC, Clark KR et al (2018b) T-cell receptor-beta V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns. Cancer Immunol Immunother: CII 67(6):885\u2013892. https:\/\/doi.org\/10.1007\/s00262-018-2139-7","journal-title":"Cancer Immunol Immunother: CII"},{"issue":"5","key":"10437_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"issue":"3","key":"10437_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11060-018-03001-1","volume":"140","author":"BI Chobrutskiy","year":"2018","unstructured":"Chobrutskiy BI, Zaman S, Tong WL, Diviney A, Blanck G (2018) Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade. J Neurooncol 140(3):697\u2013704. https:\/\/doi.org\/10.1007\/s11060-018-03001-1","journal-title":"J Neurooncol"},{"issue":"3","key":"10437_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00432-018-2815-1","volume":"145","author":"BI Chobrutskiy","year":"2019","unstructured":"Chobrutskiy BI, Zaman S, Diviney A, Mihyu MM, Blanck G (2019a) T-cell receptor-alpha CDR3 domain chemical features correlate with survival rates in bladder cancer. J Cancer Res Clin Oncol 145(3):615\u2013623. https:\/\/doi.org\/10.1007\/s00432-018-2815-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"10437_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1101-2","author":"BI Chobrutskiy","year":"2019","unstructured":"Chobrutskiy BI, Yeagley M, Tipping P, Zaman S, Diviney A, Patel DN et al (2019b) Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma. Oncogene. https:\/\/doi.org\/10.1038\/s41388-019-1101-2","journal-title":"Oncogene"},{"key":"10437_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13165","author":"BI Chobrutskiy","year":"2019","unstructured":"Chobrutskiy BI, Yeagley M, Diviney A, Zaman S, Gozlan EC, Tipping P et al (2019c) A scoring system for the electrostatic complementarities of T-cell receptors and cancer-mutant amino acids: Multi-cancer analyses of associated survival rates. Immunology. https:\/\/doi.org\/10.1111\/imm.13165","journal-title":"Immunology"},{"issue":"4","key":"10437_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/imm.13165","volume":"159","author":"BI Chobrutskiy","year":"2020","unstructured":"Chobrutskiy BI, Yeagley M, Diviney A, Zaman S, Gozlan EC, Tipping P et al (2020a) A scoring system for the electrostatic complementarities of T-cell receptors and cancer-mutant amino acids: multi-cancer analyses of associated survival rates. Immunology 159(4):373\u2013383. https:\/\/doi.org\/10.1111\/imm.13165","journal-title":"Immunology"},{"issue":"8","key":"10437_CR15","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41388-019-1101-2","volume":"39","author":"BI Chobrutskiy","year":"2020","unstructured":"Chobrutskiy BI, Yeagley M, Tipping P, Zaman S, Diviney A, Patel DN et al (2020b) Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma. Oncogene 39(8):1773\u20131783. https:\/\/doi.org\/10.1038\/s41388-019-1101-2","journal-title":"Oncogene"},{"key":"10437_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05996-6","author":"A Chobrutskiy","year":"2020","unstructured":"Chobrutskiy A, Chobrutskiy BI, Zaman S, Hsiang M, Blanck G (2020c) Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-020-05996-6","journal-title":"Breast Cancer Res Treat"},{"key":"10437_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.molimm.2021.02.026","volume":"135","author":"BI Chobrutskiy","year":"2021","unstructured":"Chobrutskiy BI, Chobrutskiy A, Zaman S, Yeagley M, Huda TI, Blanck G (2021) High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer. Mol Immunol 135:247\u2013253. https:\/\/doi.org\/10.1016\/j.molimm.2021.02.026","journal-title":"Mol Immunol"},{"issue":"1","key":"10437_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/iji.12409","volume":"46","author":"KR Clark","year":"2019","unstructured":"Clark KR, Tong WL, Callahan BM, Yavorski JM, Tu YN, Blanck G (2019) TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: comparisons with microscopic assessments of lymphocyte infiltrates. Int J Immunogenet 46(1):31\u201337. https:\/\/doi.org\/10.1111\/iji.12409","journal-title":"Int J Immunogenet"},{"key":"10437_CR19","doi-asserted-by":"publisher","first-page":"100196","DOI":"10.1016\/j.ctarc.2020.100196","volume":"24","author":"MJ Diaz","year":"2020","unstructured":"Diaz MJ, Chobrutskiy BI, Zaman S, Blanck G (2020) Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members. Cancer Treat Res Commun 24:100196. https:\/\/doi.org\/10.1016\/j.ctarc.2020.100196","journal-title":"Cancer Treat Res Commun"},{"issue":"1","key":"10437_CR20","doi-asserted-by":"publisher","first-page":"19997","DOI":"10.1038\/s41598-019-56441-8","volume":"9","author":"S Edin","year":"2019","unstructured":"Edin S, Kaprio T, Hagstrom J, Larsson P, Mustonen H, Bockelman C et al (2019) The prognostic importance of CD20(+) B lymphocytes in colorectal cancer and the relation to other immune cell subsets. Sci Rep 9(1):19997. https:\/\/doi.org\/10.1038\/s41598-019-56441-8","journal-title":"Sci Rep"},{"key":"10437_CR21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200851","author":"WH Fridman","year":"2021","unstructured":"Fridman WH, Petitprez F, Meylan M, Chen TW, Sun CM, Roumenina LT et al (2021) B cells and cancer: to B or not to B? J Exp Med. https:\/\/doi.org\/10.1084\/jem.20200851","journal-title":"J Exp Med"},{"key":"10437_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"issue":"7","key":"10437_CR23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","volume":"189","author":"C Germain","year":"2014","unstructured":"Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J et al (2014) Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med 189(7):832\u2013844. https:\/\/doi.org\/10.1164\/rccm.201309-1611OC","journal-title":"Am J Respir Crit Care Med"},{"key":"10437_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/CIN.S35784","volume":"15","author":"TR Gill","year":"2016","unstructured":"Gill TR, Samy MD, Butler SN, Mauro JA, Sexton WJ, Blanck G (2016) Detection of productively rearranged TcR-alpha V-J sequences in TCGA exome files: implications for tumor immunoscoring and recovery of antitumor T-cells. Cancer Inform 15:23\u201328. https:\/\/doi.org\/10.4137\/CIN.S35784","journal-title":"Cancer Inform"},{"key":"10437_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-021-01813-x","author":"EC Gozlan","year":"2021","unstructured":"Gozlan EC, Chobrutskiy BI, Zaman S, Yeagley M, Blanck G (2021) Systemic adaptive immune parameters associated with neuroblastoma outcomes: the significance of gamma-delta T cells. J Mol Neurosci. https:\/\/doi.org\/10.1007\/s12031-021-01813-x","journal-title":"J Mol Neurosci"},{"key":"10437_CR26","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220119","author":"TI Huda","year":"2022","unstructured":"Huda TI, Diaz MJ, Gozlan EC, Chobrutskiy A, Chobrutskiy BI, Blanck G (2022) Immunogenomics parameters for patient stratification in Alzheimer\u2019s disease. J Alzheimers Dis. https:\/\/doi.org\/10.3233\/JAD-220119","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10437_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12307-018-0205-5","volume":"11","author":"JC Kinskey","year":"2018","unstructured":"Kinskey JC, Tu YN, Tong WL, Yavorski JM, Blanck G (2018) Recovery of immunoglobulin VJ recombinations from pancreatic cancer exome files strongly correlates with reduced survival. Cancer Microenviron 11(1):51\u201359. https:\/\/doi.org\/10.1007\/s12307-018-0205-5","journal-title":"Cancer Microenviron"},{"issue":"4","key":"10437_CR28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ng.3820","volume":"49","author":"B Li","year":"2017","unstructured":"Li B, Li T, Wang B, Dou R, Zhang J, Liu JS et al (2017) Ultrasensitive detection of TCR hypervariable-region sequences in solid-tissue RNA-seq data. Nat Genet 49(4):482\u2013483. https:\/\/doi.org\/10.1038\/ng.3820","journal-title":"Nat Genet"},{"issue":"22","key":"10437_CR29","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.3390\/ijms21228479","volume":"21","author":"Z Li","year":"2020","unstructured":"Li Z, Qi F, Li F (2020) Establishment of a gene signature to predict prognosis for patients with lung adenocarcinoma. Int J Mol Sci 21(22):8479. https:\/\/doi.org\/10.3390\/ijms21228479","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10437_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/intimm\/dxx074","volume":"30","author":"AT Mai","year":"2018","unstructured":"Mai AT, Tong WL, Tu YN, Blanck G (2018) TcR-alpha recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers. Int Immunol 30(1):35\u201340. https:\/\/doi.org\/10.1093\/intimm\/dxx074","journal-title":"Int Immunol"},{"issue":"3","key":"10437_CR31","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1152\/physrev.00035.2007","volume":"88","author":"F Malavasi","year":"2008","unstructured":"Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein AL, Ortolan E et al (2008) Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology. Physiol Rev 88(3):841\u2013886. https:\/\/doi.org\/10.1152\/physrev.00035.2007","journal-title":"Physiol Rev"},{"issue":"2","key":"10437_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.semtcvs.2013.05.002","volume":"25","author":"CM North","year":"2013","unstructured":"North CM, Christiani DC (2013) Women and lung cancer: what is new? Semin Thorac Cardiovasc Surg 25(2):87\u201394. https:\/\/doi.org\/10.1053\/j.semtcvs.2013.05.002","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10437_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/iji.12550","author":"DN Patel","year":"2021","unstructured":"Patel DN, Yeagley M, Arturo JF, Falasiri S, Chobrutskiy BI, Gozlan EC et al (2021) A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma. Int J Immunogenet. https:\/\/doi.org\/10.1111\/iji.12550","journal-title":"Int J Immunogenet"},{"issue":"10","key":"10437_CR34","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1080\/07391102.2022.2070546","volume":"41","author":"AR Patel","year":"2022","unstructured":"Patel AR, Patel DN, Tu YN, Yeagley M, Chobrutskiy A, Chobrutskiy BI et al (2022) Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatments. J Biomol Struct Dyn 41(10):4632\u20134640. https:\/\/doi.org\/10.1080\/07391102.2022.2070546","journal-title":"J Biomol Struct Dyn"},{"key":"10437_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2019.01.005","author":"AM Roca","year":"2019","unstructured":"Roca AM, Chobrutskiy BI, Callahan BM, Blanck G (2019) T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates. Hum Immunol. https:\/\/doi.org\/10.1016\/j.humimm.2019.01.005","journal-title":"Hum Immunol"},{"issue":"2","key":"10437_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000485497","volume":"62","author":"KJ Salimian","year":"2018","unstructured":"Salimian KJ, Fazeli R, Zheng G, Ettinger D, Maleki Z (2018) V600E BRAF versus Non-V600E BRAF Mutated Lung Adenocarcinomas: cytomorphology, histology, coexistence of other driver mutations and patient characteristics. Acta Cytol 62(2):79\u201384. https:\/\/doi.org\/10.1159\/000485497","journal-title":"Acta Cytol"},{"issue":"3","key":"10437_CR37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00262-016-1943-1","volume":"66","author":"MD Samy","year":"2017","unstructured":"Samy MD, Tong WL, Yavorski JM, Sexton WJ, Blanck G (2017) T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-beta VDJ recombinations associates with a favorable oncologic outcome for bladder cancer. Cancer Immunol Immunother: Ceii 66(3):403\u2013410. https:\/\/doi.org\/10.1007\/s00262-016-1943-1","journal-title":"Cancer Immunol Immunother: Ceii"},{"issue":"1","key":"10437_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10437_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10437_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.21037\/tlcr.2017.03.05","volume":"6","author":"NK Taunk","year":"2007","unstructured":"Taunk NK, Rimner A, Culligan M, Friedberg JS, Brahmer J, Chaft J (2007) Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer. Trans Lung Cancer Res 6(2):178\u2013185. https:\/\/doi.org\/10.21037\/tlcr.2017.03.05","journal-title":"Trans Lung Cancer Res"},{"key":"10437_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.023","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH et al (2018) The immune landscape of cancer. Immunity. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023","journal-title":"Immunity"},{"issue":"3","key":"10437_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/21645515.2016.1246095","volume":"13","author":"WL Tong","year":"2017","unstructured":"Tong WL, Tu YN, Samy MD, Sexton WJ, Blanck G (2017) Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: evidence for high level B-cell infiltrates in breast cancer. Hum Vaccin Immunother 13(3):501\u2013506. https:\/\/doi.org\/10.1080\/21645515.2016.1246095","journal-title":"Hum Vaccin Immunother"},{"key":"10437_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4961-1","author":"WL Tong","year":"2018","unstructured":"Tong WL, Callahan BM, Tu YN, Zaman S, Chobrutskiy BI, Blanck G (2018) Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-018-4961-1","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10437_CR44","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41416-020-0797-7","volume":"122","author":"MS Toss","year":"2020","unstructured":"Toss MS, Abidi A, Lesche D, Joseph C, Mahale S, Saunders H et al (2020) The prognostic significance of immune microenvironment in breast ductal carcinoma in situ. Br J Cancer 122(10):1496\u20131506. https:\/\/doi.org\/10.1038\/s41416-020-0797-7","journal-title":"Br J Cancer"},{"issue":"11","key":"10437_CR45","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/ijc.30675","volume":"140","author":"YN Tu","year":"2017","unstructured":"Tu YN, Tong WL, Samy MD, Yavorski JM, Kim M, Blanck G (2017) Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-alpha\/beta V(D)J recombinations correlates with PD-1 expression. Int J Cancer J Int Du Cancer 140(11):2568\u20132576. https:\/\/doi.org\/10.1002\/ijc.30675","journal-title":"Int J Cancer J Int Du Cancer"},{"issue":"1","key":"10437_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12307-018-0204-6","volume":"11","author":"YN Tu","year":"2018","unstructured":"Tu YN, Tong WL, Yavorski JM, Blanck G (2018) Immunogenomics: a negative prostate cancer outcome associated with TcR-gamma\/delta recombinations. Cancer Microenviron 11(1):41\u201349. https:\/\/doi.org\/10.1007\/s12307-018-0204-6","journal-title":"Cancer Microenviron"},{"issue":"4","key":"10437_CR47","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.21873\/anticanres.14161","volume":"40","author":"YN Tu","year":"2020","unstructured":"Tu YN, Tong WL, Callahan BM, Chobrutskiy BI, Blanck G (2020) B-cell receptor recombinations in lung adenocarcinoma exome files correlate with a higher overall survival rate. Anticancer Res 40(4):2043\u20132051. https:\/\/doi.org\/10.21873\/anticanres.14161","journal-title":"Anticancer Res"},{"key":"10437_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ypmed.2016.04.015","volume":"89","author":"M Usman Ali","year":"2016","unstructured":"Usman Ali M, Miller J, Peirson L, Fitzpatrick-Lewis D, Kenny M, Sherifali D et al (2016) Screening for lung cancer: a systematic review and meta-analysis. Prev Med 89:301\u2013314. https:\/\/doi.org\/10.1016\/j.ypmed.2016.04.015","journal-title":"Prev Med"},{"issue":"1","key":"10437_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00432-019-03079-8","volume":"146","author":"B-Y Wang","year":"2020","unstructured":"Wang B-Y, Huang J-Y, Chen H-C, Lin C-H, Lin S-H, Hung W-H et al (2020) The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients. J Cancer Res Clin Oncol 146(1):43\u201352. https:\/\/doi.org\/10.1007\/s00432-019-03079-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10437_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/cells9010026","volume":"9","author":"YJ Wo","year":"2019","unstructured":"Wo YJ, Gan ASP, Lim X, Tay ISY, Lim S, Lim JCT et al (2019) The roles of CD38 and CD157 in the Solid tumor microenvironment and cancer immunotherapy. Cells 9(1):26. https:\/\/doi.org\/10.3390\/cells9010026","journal-title":"Cells"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-023-10437-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-023-10437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T19:16:43Z","timestamp":1709147803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-023-10437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10437"],"URL":"https:\/\/doi.org\/10.1007\/s10528-023-10437-2","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Access to the TCGA-LUAD and TCGA-SKCM exome files was via National Institutes of Health (NIH), database of genotypes and phenotypes (dbGaP) project approval number 6300 for George Blanck. Access to the RNAseq files was via NIH, dbGaP project approval number 20312 for George Blanck.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable (NA) (non-human subjects research).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}